Abstract
Sulpiride (SUL, 20 mg kg−1 day−1) induces weight gain, hyperphagia, hyperprolactinemia, hypogonadism, and perhaps increased insulin sensitivity in rats. Leptin seems to signal the brain about the size of body fat stores and nutrient metabolism. We evaluated the basal serum leptin levels in rats after acute (1 h) or prolonged SUL or vehicle administration (10, 20 and 30 days). At days 10 and 30 leptin was also assessed during a glucose overload test. As the maximal weight gain during SUL administration is observed at days 10–15 of treatment, leptin was measured in a comparison group of insulin-treated rats (5 IU day−1 for 10 days). SUL-treated rats significantly gained weight. However, leptin levels were not significantly increased at any time-point of treatment. SUL did not affect insulin levels either. By contrast, leptin levels were significantly elevated after insulin administration, along with weight gain and hyperinsulinemia. An opposite correlation was also observed at day 10: leptin and insulin correlated negatively in the SUL group and positively in the insulin group. In addition, leptin and the magnitude of weight gain tended to correlate positively after SUL treatment, but negatively after insulin administration. SUL-treated rats, thus, appear to exhibit an unusual type of weight gain, characterized by normal circulating leptin and insulin levels. Such a particular leptin profile may be related to hyperprolactinemia, hypogonadism or lack of hyperinsulinemia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bhavnani SM, Levin GM . Antipsychotic agents: a survey of the prevalence, severity and burden of side effects Int Clin Psychopharmacol 1996; 11: 1–12
Høyberg OJ, Fensbo C, Remvig J, Linjaerde O, Sloth-Nielsen M, Salvesen Y . Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations Acta Psychiatr Scand 1993; 88: 395–402
Leadbetter R, Shutty M, Pavalonis D, Vieweg V, Higgins P, Downs M . Clozapine-induced weight gain: prevalence and clinical relevance Am J Psychiat 1992; 149: 68–72
Olanzapine . Lilly Lab 1996 Monograph October: 71–72
Silverstone T, Smith G, Goodall E . Prevalence of obesity in patients receiving depot antipsychotics Br J Pschiat 1988; 153: 214–217
Baptista T, Parada MA, Hernández L . Long-term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved? Pharmacol Biochem Behav 1987; 27: 399–405
Baptista T, Parada MA, Murzi E . Puberty modifies sulpiride effects on body weight in rats Neurosci Lett 1988; 92: 161–164
Baptista T, Hernández L, Hoebel BG . Systemic sulpiride increases dopamine metabolites in the lateral hypothalamus Pharmacol Biochem Behav 1990; 37: 533–537
Baptista T, Murzi E, Hernández L, Burguera JL, de Burguera M . Mechanism of the sex-dependent effect of lithium on body weight in rats Pharmacol Biochem Behav 1991; 38: 533–537
Baptista T, Teneud L, Hernández L . Enhancement of amphetamine anorexia after chronic administration of sulpride in rats Pharmacol Biochem Behav 1993; 45: 45–49
Baptista T, López MA, Teneud L, Contreras Q, Alastre T, Quijada M et al. Amantadine in the treatment of neuroleptic-induced obesity in rats: behavioral, endocrine and neurochemical correlates Pharmacopsychiatry 1997; 30: 35–43
Baptista T, Araujo de Baptista E, Altemus M, Weiss SRB, Hernández L . Tamoxifen prevents sulpiride-induced obesity in rats Pharmacol Biochem Behav 1997; 57: 215–222
Baptista T, Albornoz MA, Teneud L, Contreras Q, Páez X, LaCruz A et al. Mechanism of the neuroleptic-induced obesity in female rats Prog Neuro-Psychopharmacol & Biol Psychiat 1998; 22: 187–198
Baptista T, LaCruz A, Hernández L . Glucose tolerance and serum insulin levels in an animal model of obesity induced by the antipsychotic drug sulpiride Pharmacol & Toxicol 1998; 83: 57–61
Baptista T, Alvarez L, LaCruz A, de Mendoza S, Hernández L . Glucose tolerance and serum insulin levels in an animal model of obesity induced by subacute or chronic administration of antipsychotic drugs Prog Neuro-Psychopharmacol & Biol Psychiat 1999; 23: 277–287
Parada MA, Hernández L, Páez X, Baptista T, Puig de Parada M, Quijada M . Mechanism of the sulpiride-induced obesity in rats Pharmacol Biochem Behav 1989; 33: 45–50
Shimizu H, Shimomura Y, Urhara Y, Kobayashi Y, Kobayashi Y, Kobayashi S . Involvement of sex hormone in body weight gain by selective D2 receptor antagonist sulpiride Exp Clin Endocrinol 1990; 96: 25–29
Wagssstaff AJ, Fitton A, Benfield P . Sulpiride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in schizophrenia CNS Drugs 1994; 2: 313–333
Campfield LA, Smith FJ, Burn P . The OB Protein (leptin)—a link between adipose tissue mass and central neural networks Horm Metab Res 1996; 12: 619–632
Friedman JM, Halaas JL . Leptin and the regulation of body weight in mammals Nature 1998; 22: 763–770
Remesar X, Rafecas I, Fernández-López JA, Alemany M . Leptin Medic Res Rev 1997; 17: 225–234
Woods SC, Seeley RJ, Porte D, Schwartz MW . Signals that regulate food intake and energy homeostasis Science 1998; 280: 1378–1382
Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B et al. Transient increase in obese gene expression after food intake or insulin administration Nature 1995; 377: 527–529
Yoshida T, Hayashi M, Monkawa T, Saruta T . Regulation of obese gene expression by hormonal factors in primary cultures of rats adipocytes Eur J Endocrinol 1996; 135: 619–625
Larrson H, Elmstahl S, Ahren B . Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women Diabetes 1996; 45: 1580–1584
Barash IA, Cheung CC, Weigle DS, Ren H, Kabigting EB, Kuijper JL et al. Leptin is a metabolic signal to the reproductive system Endocrinol 1996; 137: 3144–3147
Chehab FF, Mounzih K, Lu R, Lim ME . Early onset of reproductive function in normal female mice treated with leptin Science 1997; 275: 88–90
Mantzoros CS, Flier JS, Rogol AD . A longitudinal assessment of hormonal and physical alternations during normal puberty in boys. Rising leptin levels may signal the onset of puberty J Clin Endocrinol Metab 1997; 82: 1066–1070
Bromel T, Blum WF, Zeigler A, Schulz E, Bender M, Fleischhaker C et al. Serum leptin levels increase rapidily after initiation of clozapine therapy Mol Psychiatry 1998; 3: 76–80
Kraus T, Haack M, Schuld A, Hinze-Selch D, Kuhn M, Uhr M et al. Body weight and leptin plasma levels during treatment with antipsychotic drugs Am J Psychiatry 1999; 2: 312–314
ILAR Committee on Care and Use of Laboratory Animals . Guide for the Care and Use of Laboratory Animals. NIH Pub. No. 86–23 US Department of Health and Human Services: Washington DC 1985
Mueller WM, Gregoire FC, Stanhope KL, Mobbs CV, Mizuno TM, Warden CH et al. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes Endocrinology 1998; 139: 551–558
Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L . A nutrient-sensing pathway regulates leptin gene expression in muscle and fat Nature 1998; 393: 684–688
Baptista T, Molina MG, Martinez JL, Quijada M, Calanche I, Acosta A et al. Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy premenopausal women: relationship with body weight regulation Pharmacopsychiatry 1997; 30: 256–262
Acknowledgements
This paper was supported by CONICIT Grants S196000775, and 97003895024.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lacruz, A., Baptista, T., de Mendoza, S. et al. Antipsychotic drug-induced obesity in rats: correlation between leptin, insulin and body weight during sulpiride treatment. Mol Psychiatry 5, 70–76 (2000). https://doi.org/10.1038/sj.mp.4000566
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000566
Keywords
This article is cited by
-
Access to the CNS: Biomarker Strategies for Dopaminergic Treatments
Pharmaceutical Research (2018)
-
Obesity impairs lactation performance in mice by inducing prolactin resistance
Scientific Reports (2016)
-
The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats
Psychopharmacology (2007)
-
Topiramate stimulates glucose transport through AMP-activated protein kinase-mediated pathway in L6 skeletal muscle cells
The Pharmacogenomics Journal (2006)
-
Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats
Psychopharmacology (2005)